share_log

再鼎医药(09688.HK)获摩根大通增持118.31万股普通股股份,价值约2,905.66万港元

Zai Lab (09688.HK) received a shareholding of 1.1831 million ordinary shares from JPMorgan, worth approximately 29.0566 million Hong Kong dollars.

Futu News ·  Nov 15 17:04

Reported on November 15th, according to the documents disclosed by the Hong Kong Stock Exchange on November 15th, JPMorgan Chase & Co. increased its shareholding by acquiring an average on-exchange price of HK$24.5597 per share and an average off-exchange price of HK$24.6103 per share on November 11th, totaling 1.1831 million ordinary shares, with a total value of approximately HK$29.0566 million.$ZAI LAB (09688.HK)$After the shareholding increase, JPMorgan Chase's latest number of shares held is 0.14 billion shares, with the stake ratio rising from 13.89% to 14.01%.

HKEXAutoNews_CS20241114E00443.png

What is equity disclosure?

According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.

Why is equity disclosure important?

Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment